Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
18 hedge funds and large institutions have $578K invested in Intellipharmaceuticals International Inc. in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 8 closing their positions.
732% more call options, than puts
Call options by funds: $158K | Put options by funds: $19K
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
14% less funds holding
Funds holding: 21 → 18 (-3)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
45% less capital invested
Capital invested by funds: $1.05M → $578K (-$475K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$82.9K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$26.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$26.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$25.1K |
| 5 |
Morgan Stanley
New York
|
+$11.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFA
First Foundation Advisors
Irvine,
California
|
-$202K |
| 2 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$170K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$77K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$25.7K |
| 5 |
AIG
American International Group
New York
|
-$10K |
IPCI Hedge Fund Activity: Q2 2016 in Review
18 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q2 2016, worth a combined $578K — down 45% from $1.05M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IPCI and 5 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 6 added.
The largest buyer was Royal Bank of Canada, adding an estimated $82.9K. The largest seller was First Foundation Advisors, exiting entirely with an estimated $202K sold.
- 18 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q2 2016, down from 21 in Q1 2016.
- Funds reported $578K of Intellipharmaceuticals International Inc. stock for Q2 2016, down 45% quarter-over-quarter.
- 5 funds opened new Intellipharmaceuticals International Inc. positions in Q2 2016 and 8 closed out, a net change of -3 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q2 2016 was Royal Bank of Canada, an estimated $82.9K added.
- The largest Intellipharmaceuticals International Inc. seller in Q2 2016 was First Foundation Advisors, an estimated $202K sold.
Based on aggregated 13F filings for Q2 2016.